These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5801188)

  • 21. The blood volume expansion produced by gelatin, serum albumin, and plasma.
    HYDE GM; BERLIN NI; PARSONS RJ; WHITTINGTON B
    Surg Gynecol Obstet; 1952 Dec; 95(6):657-60. PubMed ID: 13005337
    [No Abstract]   [Full Text] [Related]  

  • 22. [A SIMPLE METHOD FOR MEASURING THE RELATIVE ONCOTIC EFFECTIVENESS OF COLLOIDAL PLASMA SUBSTITUTE SOLUTIONS].
    NITSCHMANN H; GYGAX HR
    Pathol Microbiol (Basel); 1964; 27():548-57. PubMed ID: 14178193
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacodynamics of plasma substitutes].
    Mas Marfany J
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):108-14. PubMed ID: 5552978
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood substitutes.
    Kostrzewska E
    Ann R Coll Surg Engl; 1976 Mar; 58(2):115-25. PubMed ID: 57736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood volume and plasma protein. 3. Changes in blood volume and plasma proteins after bleeding and immediate substitution with Macrodex, Rheomacrodex and Physiogel in the splenecromized dog.
    Rieger A
    Acta Chir Scand Suppl; 1967; 379():22-38. PubMed ID: 5243638
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood volume and plasma protein. IV. Importance of thoracic-duct lymph in restitution of plasma volume and plasma proteins after bleeding and immediate substitution in the splenectomized dog.
    Liljedahl SO; Rieger A
    Acta Chir Scand Suppl; 1967; 379():39-5. PubMed ID: 5243639
    [No Abstract]   [Full Text] [Related]  

  • 27. [THERAPEUTIC EFFECTS OF VARIOUS PLASMA-EXPANDERS IN EXPERIMENTAL HEMORRHAGIC SHOCK].
    BURRI C; ALLGOEWER M
    Chirurg; 1965 Jan; 36():1-4. PubMed ID: 14267763
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical use of plasma fractions.
    Hässig A
    Haematologia (Budap); 1974; 8(1-4):393-400. PubMed ID: 4142622
    [No Abstract]   [Full Text] [Related]  

  • 29. A review on the status of the so-called blood plasma substitutes.
    ATIENZA RY; ZALAMEA RU
    J Philipp Med Assoc; 1954 Jul; 30(7):346-57. PubMed ID: 13202054
    [No Abstract]   [Full Text] [Related]  

  • 30. [HES, dextran and gelatin--indications and tolerance].
    Laubenthal H; Sirtl C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
    [No Abstract]   [Full Text] [Related]  

  • 31. [Indications and contraindications for plasma substitutes in operative medicine].
    Simon J; Racenberg E
    Anasth Intensivther Notfallmed; 1981 Apr; 16(2):83-8. PubMed ID: 6167174
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood and colloidal plasma volume expanders. Blood circulation changes and differential indication].
    Thimme W; Dissmann W; Eisele R
    Med Welt; 1970 Mar; 12():477-8 passim. PubMed ID: 5444235
    [No Abstract]   [Full Text] [Related]  

  • 33. TRANSFUSION FLUIDS.
    BULL JP
    Ann R Coll Surg Engl; 1963 Sep; 33(3):175-84. PubMed ID: 14048754
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal function, blood volume reaction and hemostatic changes after an infusion of a plasma substitute with a gelatin base].
    Pflueger H
    Rev Bras Anestesiol; 1969; 19(2):260-70. PubMed ID: 5352461
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
    Ring J; Seifert J; Struif E; Messmer K; Brendel W
    Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood and blood substitutes for treating hemorragic shock.
    Buchanan EC
    Am J Hosp Pharm; 1977 Jun; 34(6):631-6. PubMed ID: 879185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of hemostasis disorders due to infusions].
    Perlick E
    Z Gesamte Inn Med; 1970 Aug; 25(15):666-71. PubMed ID: 5527529
    [No Abstract]   [Full Text] [Related]  

  • 38. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasma substitutes].
    Lundsgaard-Hansen P
    Schweiz Med Wochenschr; 1968 Aug; 98(34):1273-81. PubMed ID: 5682776
    [No Abstract]   [Full Text] [Related]  

  • 39. Modified fluid gelatin as a plasma substitute.
    Lundsgaard-Hansen P; Tschirren B
    Prog Clin Biol Res; 1978; 19():227-57. PubMed ID: 351631
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of nonblood plasma substitutes: less frequently discussed issues.
    Boldt J
    Eur J Anaesthesiol; 2010 Jun; 27(6):495-500. PubMed ID: 20179599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.